Thetis Pharmaceuticals Receives $1,500,000 New Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=514dfe79-bc43-443e-8a30-9da7cbb02edd&Preview=1 -
Date
8/22/2011 -
Company Name
Thetis Pharmaceuticals -
Mailing Address
167 Old Post Rd Southport, CT 06890 -
Company Description
The company is developing treatments for for diabetes-related diseases. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$1,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The company expects to begin clinical studies with TP101 in 2012, an exceptionally rapid timeline made possible by certain regulatory efficiencies associated with the metformin / omega-3 chemical composition of the drug candidate. -
M&A Terms
-
Venture Investor
Connecticut Innovations -
Venture Investor
Stonehenge Capital -
Venture Investor
Undisclosed
